HIV-1 Antigen (p24)

What is HIV-1 Antigen (p24)?

Detects the p24 antigen, an HIV-1 protein that appears before antibodies develop, allowing earlier detection of infection.

The HIV-1 p24 antigen test looks directly for a structural protein of the human immunodeficiency virus that becomes detectable in blood sooner after exposure than antibodies do, narrowing the window period during which an infection might otherwise go undetected. It is usually included as part of a combined antigen/antibody screening test rather than run entirely on its own. This test relates to the immune system and is central to early HIV detection efforts. Clinicians commonly order it as part of routine HIV screening, after a recent potential exposure, or when early HIV infection with flu-like symptoms is suspected, since catching an infection early supports timely care and reduces the chance of onward transmission.

Lifestyle factors that influence this marker

• Use condoms and other barrier methods consistently to reduce exposure risk
• Discuss HIV prevention options such as PrEP with a healthcare professional if ongoing risk factors are present
• Avoid sharing needles or other injection equipment
• Communicate openly with partners about HIV status and testing history
• Schedule follow-up testing after the recommended window period if a recent exposure occurred

Tests often checked alongside this

• HIV-1/2 Antibodies — commonly combined with antigen testing in a single assay
• HIV RNA (NAT) — used to detect virus even earlier than antigen testing
• HIV-1 Differentiation Ab — used to confirm and distinguish HIV type after a reactive screen
• Syphilis RPR — often screened alongside as part of comprehensive sexual health testing

How this can show up in how you look and feel

• Early HIV infection can cause flu-like symptoms such as fever, fatigue, and swollen glands, though many people notice nothing unusual
• Most people with a reactive result have no distinguishing symptoms at the time of testing

What can affect this marker

• Time elapsed since a potential exposure, since antigen levels change over the course of infection
• Recent illness or immune system activity
• Type of test used (stand-alone antigen versus combined antigen/antibody assay)

What to track over time

• Whether repeat testing is needed after the recommended window period following a recent exposure
• Results of follow-up confirmatory or differentiation testing if the initial result is reactive
• Any new symptoms or exposures that might prompt earlier retesting

What to ask your doctor

• Given my exposure timing, is this the right test or should I also consider a NAT test?
• If my result is reactive, what confirmatory testing follows?
• How soon should I retest if my result is negative but exposure was recent?
• Are there prevention options, like PrEP, that make sense for my situation?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.